1. From the Department of Atherosclerosis (G.L., J.-C.F.), SERLIA-INSERM UR545, Institut Pasteur de Lille and University Lille II, France; U.F.R. of Pharmacy (J.-M.B.), INSERM UR539, Nantes, France; Department of Hematology (I.J.-V.), Hôpital de la Timone, Marseille, France; Toulouse MONICA Project (J.F.), INSERM U588, Department of Epidemiology, Paul Sabatier-Toulouse Purpan University, Toulouse, France; Department of Epidemiology and Public Health (A.E.), Queen’s University Belfast, Northern...